nodes	percent_of_prediction	percent_of_DWPC	metapath
Acebutolol—CYP2D6—breast cancer	0.219	0.583	CbGaD
Acebutolol—ABCB1—breast cancer	0.156	0.417	CbGaD
Acebutolol—ABCB1—Toremifene—breast cancer	0.0509	0.157	CbGbCtD
Acebutolol—CYP2D6—Idarubicin—breast cancer	0.0397	0.122	CbGbCtD
Acebutolol—ABCB1—Lapatinib—breast cancer	0.0371	0.114	CbGbCtD
Acebutolol—ABCB1—Vinorelbine—breast cancer	0.0206	0.0635	CbGbCtD
Acebutolol—CYP2D6—Vinorelbine—breast cancer	0.0194	0.0598	CbGbCtD
Acebutolol—ABCB1—Tamoxifen—breast cancer	0.0186	0.0573	CbGbCtD
Acebutolol—ABCB1—Mitoxantrone—breast cancer	0.0181	0.0559	CbGbCtD
Acebutolol—CYP2D6—Tamoxifen—breast cancer	0.0175	0.054	CbGbCtD
Acebutolol—ABCB1—Gemcitabine—breast cancer	0.016	0.0493	CbGbCtD
Acebutolol—ABCB1—Paclitaxel—breast cancer	0.0145	0.0446	CbGbCtD
Acebutolol—ABCB1—Irinotecan—breast cancer	0.0143	0.044	CbGbCtD
Acebutolol—ABCB1—Vinblastine—breast cancer	0.0127	0.0391	CbGbCtD
Acebutolol—CYP2D6—Vinblastine—breast cancer	0.012	0.0368	CbGbCtD
Acebutolol—ABCB1—Docetaxel—breast cancer	0.0105	0.0322	CbGbCtD
Acebutolol—ABCB1—Doxorubicin—breast cancer	0.00779	0.024	CbGbCtD
Acebutolol—ABCB1—Methotrexate—breast cancer	0.00755	0.0233	CbGbCtD
Acebutolol—CYP2D6—Doxorubicin—breast cancer	0.00734	0.0226	CbGbCtD
Acebutolol—Betaxolol—CYP2D6—breast cancer	0.000288	0.114	CrCbGaD
Acebutolol—Bisoprolol—CYP2D6—breast cancer	0.000278	0.11	CrCbGaD
Acebutolol—Oxprenolol—CYP2D6—breast cancer	0.000261	0.103	CrCbGaD
Acebutolol—Alprenolol—CYP2D6—breast cancer	0.000239	0.0943	CrCbGaD
Acebutolol—Bisoprolol—CYP3A4—breast cancer	0.000238	0.0941	CrCbGaD
Acebutolol—Metoprolol—CYP2D6—breast cancer	0.000222	0.0877	CrCbGaD
Acebutolol—Pindolol—CYP2D6—breast cancer	0.000206	0.0812	CrCbGaD
Acebutolol—Atenolol—ABCB1—breast cancer	0.000204	0.0804	CrCbGaD
Acebutolol—Metoprolol—ABCB1—breast cancer	0.000159	0.0626	CrCbGaD
Acebutolol—Propranolol—CYP1A1—breast cancer	0.000151	0.0595	CrCbGaD
Acebutolol—Propranolol—CYP2D6—breast cancer	0.000112	0.0443	CrCbGaD
Acebutolol—Propranolol—CYP3A4—breast cancer	9.62e-05	0.038	CrCbGaD
Acebutolol—Propranolol—ABCB1—breast cancer	8.01e-05	0.0316	CrCbGaD
Acebutolol—Sweating—Doxorubicin—breast cancer	6.44e-05	0.000273	CcSEcCtD
Acebutolol—Urticaria—Paclitaxel—breast cancer	6.43e-05	0.000273	CcSEcCtD
Acebutolol—Hyperhidrosis—Capecitabine—breast cancer	6.42e-05	0.000273	CcSEcCtD
Acebutolol—Hypotension—Docetaxel—breast cancer	6.41e-05	0.000272	CcSEcCtD
Acebutolol—Connective tissue disorder—Epirubicin—breast cancer	6.4e-05	0.000272	CcSEcCtD
Acebutolol—Abdominal pain—Paclitaxel—breast cancer	6.4e-05	0.000272	CcSEcCtD
Acebutolol—Body temperature increased—Paclitaxel—breast cancer	6.4e-05	0.000272	CcSEcCtD
Acebutolol—Anorexia—Capecitabine—breast cancer	6.33e-05	0.000269	CcSEcCtD
Acebutolol—Angiopathy—Methotrexate—breast cancer	6.32e-05	0.000268	CcSEcCtD
Acebutolol—Vomiting—Irinotecan—breast cancer	6.31e-05	0.000268	CcSEcCtD
Acebutolol—Vomiting—Mitoxantrone—breast cancer	6.31e-05	0.000268	CcSEcCtD
Acebutolol—Dizziness—Fluorouracil—breast cancer	6.29e-05	0.000267	CcSEcCtD
Acebutolol—Visual impairment—Epirubicin—breast cancer	6.28e-05	0.000267	CcSEcCtD
Acebutolol—Mediastinal disorder—Methotrexate—breast cancer	6.28e-05	0.000266	CcSEcCtD
Acebutolol—Agranulocytosis—Doxorubicin—breast cancer	6.27e-05	0.000266	CcSEcCtD
Acebutolol—Rash—Irinotecan—breast cancer	6.26e-05	0.000266	CcSEcCtD
Acebutolol—Rash—Mitoxantrone—breast cancer	6.26e-05	0.000266	CcSEcCtD
Acebutolol—Dermatitis—Mitoxantrone—breast cancer	6.25e-05	0.000266	CcSEcCtD
Acebutolol—Dermatitis—Irinotecan—breast cancer	6.25e-05	0.000266	CcSEcCtD
Acebutolol—Musculoskeletal discomfort—Docetaxel—breast cancer	6.25e-05	0.000265	CcSEcCtD
Acebutolol—Chills—Methotrexate—breast cancer	6.25e-05	0.000265	CcSEcCtD
Acebutolol—Headache—Mitoxantrone—breast cancer	6.22e-05	0.000264	CcSEcCtD
Acebutolol—Headache—Irinotecan—breast cancer	6.22e-05	0.000264	CcSEcCtD
Acebutolol—Hypotension—Capecitabine—breast cancer	6.21e-05	0.000264	CcSEcCtD
Acebutolol—Insomnia—Docetaxel—breast cancer	6.21e-05	0.000264	CcSEcCtD
Acebutolol—Paraesthesia—Docetaxel—breast cancer	6.16e-05	0.000262	CcSEcCtD
Acebutolol—Alopecia—Methotrexate—breast cancer	6.15e-05	0.000261	CcSEcCtD
Acebutolol—Vomiting—Gemcitabine—breast cancer	6.15e-05	0.000261	CcSEcCtD
Acebutolol—Bradycardia—Doxorubicin—breast cancer	6.14e-05	0.000261	CcSEcCtD
Acebutolol—Dyspnoea—Docetaxel—breast cancer	6.12e-05	0.00026	CcSEcCtD
Acebutolol—Somnolence—Docetaxel—breast cancer	6.1e-05	0.000259	CcSEcCtD
Acebutolol—Rash—Gemcitabine—breast cancer	6.1e-05	0.000259	CcSEcCtD
Acebutolol—Dermatitis—Gemcitabine—breast cancer	6.09e-05	0.000259	CcSEcCtD
Acebutolol—Tinnitus—Epirubicin—breast cancer	6.08e-05	0.000258	CcSEcCtD
Acebutolol—Headache—Gemcitabine—breast cancer	6.06e-05	0.000257	CcSEcCtD
Acebutolol—Musculoskeletal discomfort—Capecitabine—breast cancer	6.05e-05	0.000257	CcSEcCtD
Acebutolol—Flushing—Epirubicin—breast cancer	6.05e-05	0.000257	CcSEcCtD
Acebutolol—Vomiting—Fluorouracil—breast cancer	6.05e-05	0.000257	CcSEcCtD
Acebutolol—Rhinitis—Doxorubicin—breast cancer	6.04e-05	0.000257	CcSEcCtD
Acebutolol—Dyspepsia—Docetaxel—breast cancer	6.04e-05	0.000256	CcSEcCtD
Acebutolol—Insomnia—Capecitabine—breast cancer	6.01e-05	0.000255	CcSEcCtD
Acebutolol—Hypoaesthesia—Doxorubicin—breast cancer	6e-05	0.000255	CcSEcCtD
Acebutolol—Rash—Fluorouracil—breast cancer	6e-05	0.000255	CcSEcCtD
Acebutolol—Dermatitis—Fluorouracil—breast cancer	5.99e-05	0.000254	CcSEcCtD
Acebutolol—Pharyngitis—Doxorubicin—breast cancer	5.98e-05	0.000254	CcSEcCtD
Acebutolol—Paraesthesia—Capecitabine—breast cancer	5.97e-05	0.000253	CcSEcCtD
Acebutolol—Decreased appetite—Docetaxel—breast cancer	5.97e-05	0.000253	CcSEcCtD
Acebutolol—Headache—Fluorouracil—breast cancer	5.96e-05	0.000253	CcSEcCtD
Acebutolol—Gastrointestinal disorder—Docetaxel—breast cancer	5.93e-05	0.000252	CcSEcCtD
Acebutolol—Connective tissue disorder—Doxorubicin—breast cancer	5.93e-05	0.000252	CcSEcCtD
Acebutolol—Dyspnoea—Capecitabine—breast cancer	5.92e-05	0.000252	CcSEcCtD
Acebutolol—Fatigue—Docetaxel—breast cancer	5.92e-05	0.000251	CcSEcCtD
Acebutolol—Angiopathy—Epirubicin—breast cancer	5.91e-05	0.000251	CcSEcCtD
Acebutolol—Nausea—Irinotecan—breast cancer	5.9e-05	0.00025	CcSEcCtD
Acebutolol—Nausea—Mitoxantrone—breast cancer	5.9e-05	0.00025	CcSEcCtD
Acebutolol—Mediastinal disorder—Epirubicin—breast cancer	5.87e-05	0.000249	CcSEcCtD
Acebutolol—Constipation—Docetaxel—breast cancer	5.87e-05	0.000249	CcSEcCtD
Acebutolol—Pain—Docetaxel—breast cancer	5.87e-05	0.000249	CcSEcCtD
Acebutolol—Back pain—Methotrexate—breast cancer	5.86e-05	0.000249	CcSEcCtD
Acebutolol—Dyspepsia—Capecitabine—breast cancer	5.85e-05	0.000248	CcSEcCtD
Acebutolol—Chills—Epirubicin—breast cancer	5.85e-05	0.000248	CcSEcCtD
Acebutolol—Visual impairment—Doxorubicin—breast cancer	5.81e-05	0.000247	CcSEcCtD
Acebutolol—Asthenia—Paclitaxel—breast cancer	5.81e-05	0.000247	CcSEcCtD
Acebutolol—Decreased appetite—Capecitabine—breast cancer	5.78e-05	0.000245	CcSEcCtD
Acebutolol—Alopecia—Epirubicin—breast cancer	5.76e-05	0.000244	CcSEcCtD
Acebutolol—Nausea—Gemcitabine—breast cancer	5.75e-05	0.000244	CcSEcCtD
Acebutolol—Gastrointestinal disorder—Capecitabine—breast cancer	5.74e-05	0.000244	CcSEcCtD
Acebutolol—Fatigue—Capecitabine—breast cancer	5.73e-05	0.000243	CcSEcCtD
Acebutolol—Pruritus—Paclitaxel—breast cancer	5.73e-05	0.000243	CcSEcCtD
Acebutolol—Vision blurred—Methotrexate—breast cancer	5.71e-05	0.000243	CcSEcCtD
Acebutolol—Constipation—Capecitabine—breast cancer	5.68e-05	0.000241	CcSEcCtD
Acebutolol—Pain—Capecitabine—breast cancer	5.68e-05	0.000241	CcSEcCtD
Acebutolol—Feeling abnormal—Docetaxel—breast cancer	5.66e-05	0.00024	CcSEcCtD
Acebutolol—Nausea—Fluorouracil—breast cancer	5.65e-05	0.00024	CcSEcCtD
Acebutolol—Ill-defined disorder—Methotrexate—breast cancer	5.62e-05	0.000239	CcSEcCtD
Acebutolol—Tinnitus—Doxorubicin—breast cancer	5.62e-05	0.000239	CcSEcCtD
Acebutolol—Gastrointestinal pain—Docetaxel—breast cancer	5.61e-05	0.000238	CcSEcCtD
Acebutolol—Flushing—Doxorubicin—breast cancer	5.6e-05	0.000238	CcSEcCtD
Acebutolol—Flatulence—Epirubicin—breast cancer	5.59e-05	0.000237	CcSEcCtD
Acebutolol—Diarrhoea—Paclitaxel—breast cancer	5.54e-05	0.000235	CcSEcCtD
Acebutolol—Back pain—Epirubicin—breast cancer	5.49e-05	0.000233	CcSEcCtD
Acebutolol—Feeling abnormal—Capecitabine—breast cancer	5.48e-05	0.000232	CcSEcCtD
Acebutolol—Angiopathy—Doxorubicin—breast cancer	5.47e-05	0.000232	CcSEcCtD
Acebutolol—Malaise—Methotrexate—breast cancer	5.47e-05	0.000232	CcSEcCtD
Acebutolol—Vertigo—Methotrexate—breast cancer	5.45e-05	0.000231	CcSEcCtD
Acebutolol—Gastrointestinal pain—Capecitabine—breast cancer	5.43e-05	0.000231	CcSEcCtD
Acebutolol—Mediastinal disorder—Doxorubicin—breast cancer	5.43e-05	0.000231	CcSEcCtD
Acebutolol—Abdominal pain—Docetaxel—breast cancer	5.43e-05	0.00023	CcSEcCtD
Acebutolol—Body temperature increased—Docetaxel—breast cancer	5.43e-05	0.00023	CcSEcCtD
Acebutolol—Chills—Doxorubicin—breast cancer	5.41e-05	0.00023	CcSEcCtD
Acebutolol—Dizziness—Paclitaxel—breast cancer	5.35e-05	0.000227	CcSEcCtD
Acebutolol—Vision blurred—Epirubicin—breast cancer	5.35e-05	0.000227	CcSEcCtD
Acebutolol—Alopecia—Doxorubicin—breast cancer	5.33e-05	0.000226	CcSEcCtD
Acebutolol—Cough—Methotrexate—breast cancer	5.29e-05	0.000225	CcSEcCtD
Acebutolol—Urticaria—Capecitabine—breast cancer	5.28e-05	0.000224	CcSEcCtD
Acebutolol—Ill-defined disorder—Epirubicin—breast cancer	5.26e-05	0.000223	CcSEcCtD
Acebutolol—Abdominal pain—Capecitabine—breast cancer	5.25e-05	0.000223	CcSEcCtD
Acebutolol—Body temperature increased—Capecitabine—breast cancer	5.25e-05	0.000223	CcSEcCtD
Acebutolol—Flatulence—Doxorubicin—breast cancer	5.17e-05	0.00022	CcSEcCtD
Acebutolol—Arthralgia—Methotrexate—breast cancer	5.16e-05	0.000219	CcSEcCtD
Acebutolol—Myalgia—Methotrexate—breast cancer	5.16e-05	0.000219	CcSEcCtD
Acebutolol—Chest pain—Methotrexate—breast cancer	5.16e-05	0.000219	CcSEcCtD
Acebutolol—Vomiting—Paclitaxel—breast cancer	5.15e-05	0.000219	CcSEcCtD
Acebutolol—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—breast cancer	5.13e-05	0.000218	CcSEcCtD
Acebutolol—Malaise—Epirubicin—breast cancer	5.12e-05	0.000217	CcSEcCtD
Acebutolol—Rash—Paclitaxel—breast cancer	5.11e-05	0.000217	CcSEcCtD
Acebutolol—Dermatitis—Paclitaxel—breast cancer	5.1e-05	0.000217	CcSEcCtD
Acebutolol—Discomfort—Methotrexate—breast cancer	5.1e-05	0.000216	CcSEcCtD
Acebutolol—Vertigo—Epirubicin—breast cancer	5.1e-05	0.000216	CcSEcCtD
Acebutolol—Syncope—Epirubicin—breast cancer	5.09e-05	0.000216	CcSEcCtD
Acebutolol—Back pain—Doxorubicin—breast cancer	5.08e-05	0.000216	CcSEcCtD
Acebutolol—Headache—Paclitaxel—breast cancer	5.07e-05	0.000215	CcSEcCtD
Acebutolol—Palpitations—Epirubicin—breast cancer	5.01e-05	0.000213	CcSEcCtD
Acebutolol—Confusional state—Methotrexate—breast cancer	4.99e-05	0.000212	CcSEcCtD
Acebutolol—Loss of consciousness—Epirubicin—breast cancer	4.99e-05	0.000212	CcSEcCtD
Acebutolol—Cough—Epirubicin—breast cancer	4.95e-05	0.00021	CcSEcCtD
Acebutolol—Vision blurred—Doxorubicin—breast cancer	4.95e-05	0.00021	CcSEcCtD
Acebutolol—Asthenia—Docetaxel—breast cancer	4.92e-05	0.000209	CcSEcCtD
Acebutolol—Ill-defined disorder—Doxorubicin—breast cancer	4.87e-05	0.000207	CcSEcCtD
Acebutolol—Pruritus—Docetaxel—breast cancer	4.86e-05	0.000206	CcSEcCtD
Acebutolol—Nervous system disorder—Methotrexate—breast cancer	4.85e-05	0.000206	CcSEcCtD
Acebutolol—Myalgia—Epirubicin—breast cancer	4.83e-05	0.000205	CcSEcCtD
Acebutolol—Arthralgia—Epirubicin—breast cancer	4.83e-05	0.000205	CcSEcCtD
Acebutolol—Chest pain—Epirubicin—breast cancer	4.83e-05	0.000205	CcSEcCtD
Acebutolol—Anxiety—Epirubicin—breast cancer	4.81e-05	0.000204	CcSEcCtD
Acebutolol—Nausea—Paclitaxel—breast cancer	4.81e-05	0.000204	CcSEcCtD
Acebutolol—Skin disorder—Methotrexate—breast cancer	4.81e-05	0.000204	CcSEcCtD
Acebutolol—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—breast cancer	4.8e-05	0.000204	CcSEcCtD
Acebutolol—Hyperhidrosis—Methotrexate—breast cancer	4.78e-05	0.000203	CcSEcCtD
Acebutolol—Discomfort—Epirubicin—breast cancer	4.77e-05	0.000203	CcSEcCtD
Acebutolol—Asthenia—Capecitabine—breast cancer	4.77e-05	0.000202	CcSEcCtD
Acebutolol—Malaise—Doxorubicin—breast cancer	4.73e-05	0.000201	CcSEcCtD
Acebutolol—Vertigo—Doxorubicin—breast cancer	4.72e-05	0.0002	CcSEcCtD
Acebutolol—Anorexia—Methotrexate—breast cancer	4.72e-05	0.0002	CcSEcCtD
Acebutolol—Syncope—Doxorubicin—breast cancer	4.71e-05	0.0002	CcSEcCtD
Acebutolol—Pruritus—Capecitabine—breast cancer	4.7e-05	0.0002	CcSEcCtD
Acebutolol—Diarrhoea—Docetaxel—breast cancer	4.7e-05	0.000199	CcSEcCtD
Acebutolol—Confusional state—Epirubicin—breast cancer	4.67e-05	0.000198	CcSEcCtD
Acebutolol—Palpitations—Doxorubicin—breast cancer	4.64e-05	0.000197	CcSEcCtD
Acebutolol—Oedema—Epirubicin—breast cancer	4.63e-05	0.000197	CcSEcCtD
Acebutolol—Hypotension—Methotrexate—breast cancer	4.62e-05	0.000196	CcSEcCtD
Acebutolol—Loss of consciousness—Doxorubicin—breast cancer	4.61e-05	0.000196	CcSEcCtD
Acebutolol—Cough—Doxorubicin—breast cancer	4.58e-05	0.000194	CcSEcCtD
Acebutolol—Shock—Epirubicin—breast cancer	4.55e-05	0.000193	CcSEcCtD
Acebutolol—Diarrhoea—Capecitabine—breast cancer	4.55e-05	0.000193	CcSEcCtD
Acebutolol—Nervous system disorder—Epirubicin—breast cancer	4.54e-05	0.000193	CcSEcCtD
Acebutolol—Dizziness—Docetaxel—breast cancer	4.54e-05	0.000193	CcSEcCtD
Acebutolol—Musculoskeletal discomfort—Methotrexate—breast cancer	4.51e-05	0.000191	CcSEcCtD
Acebutolol—Skin disorder—Epirubicin—breast cancer	4.5e-05	0.000191	CcSEcCtD
Acebutolol—Hyperhidrosis—Epirubicin—breast cancer	4.48e-05	0.00019	CcSEcCtD
Acebutolol—Insomnia—Methotrexate—breast cancer	4.47e-05	0.00019	CcSEcCtD
Acebutolol—Chest pain—Doxorubicin—breast cancer	4.47e-05	0.00019	CcSEcCtD
Acebutolol—Myalgia—Doxorubicin—breast cancer	4.47e-05	0.00019	CcSEcCtD
Acebutolol—Arthralgia—Doxorubicin—breast cancer	4.47e-05	0.00019	CcSEcCtD
Acebutolol—Anxiety—Doxorubicin—breast cancer	4.45e-05	0.000189	CcSEcCtD
Acebutolol—Paraesthesia—Methotrexate—breast cancer	4.44e-05	0.000189	CcSEcCtD
Acebutolol—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—breast cancer	4.44e-05	0.000188	CcSEcCtD
Acebutolol—Discomfort—Doxorubicin—breast cancer	4.42e-05	0.000187	CcSEcCtD
Acebutolol—Anorexia—Epirubicin—breast cancer	4.41e-05	0.000187	CcSEcCtD
Acebutolol—Dyspnoea—Methotrexate—breast cancer	4.41e-05	0.000187	CcSEcCtD
Acebutolol—Somnolence—Methotrexate—breast cancer	4.4e-05	0.000187	CcSEcCtD
Acebutolol—Dizziness—Capecitabine—breast cancer	4.39e-05	0.000187	CcSEcCtD
Acebutolol—Vomiting—Docetaxel—breast cancer	4.36e-05	0.000185	CcSEcCtD
Acebutolol—Dyspepsia—Methotrexate—breast cancer	4.35e-05	0.000185	CcSEcCtD
Acebutolol—Rash—Docetaxel—breast cancer	4.33e-05	0.000184	CcSEcCtD
Acebutolol—Hypotension—Epirubicin—breast cancer	4.33e-05	0.000184	CcSEcCtD
Acebutolol—Dermatitis—Docetaxel—breast cancer	4.32e-05	0.000184	CcSEcCtD
Acebutolol—Confusional state—Doxorubicin—breast cancer	4.32e-05	0.000183	CcSEcCtD
Acebutolol—Decreased appetite—Methotrexate—breast cancer	4.3e-05	0.000183	CcSEcCtD
Acebutolol—Headache—Docetaxel—breast cancer	4.3e-05	0.000183	CcSEcCtD
Acebutolol—Oedema—Doxorubicin—breast cancer	4.28e-05	0.000182	CcSEcCtD
Acebutolol—Gastrointestinal disorder—Methotrexate—breast cancer	4.27e-05	0.000181	CcSEcCtD
Acebutolol—Fatigue—Methotrexate—breast cancer	4.27e-05	0.000181	CcSEcCtD
Acebutolol—Pain—Methotrexate—breast cancer	4.23e-05	0.00018	CcSEcCtD
Acebutolol—Vomiting—Capecitabine—breast cancer	4.23e-05	0.000179	CcSEcCtD
Acebutolol—Musculoskeletal discomfort—Epirubicin—breast cancer	4.22e-05	0.000179	CcSEcCtD
Acebutolol—Shock—Doxorubicin—breast cancer	4.21e-05	0.000179	CcSEcCtD
Acebutolol—Nervous system disorder—Doxorubicin—breast cancer	4.2e-05	0.000178	CcSEcCtD
Acebutolol—Rash—Capecitabine—breast cancer	4.19e-05	0.000178	CcSEcCtD
Acebutolol—Insomnia—Epirubicin—breast cancer	4.19e-05	0.000178	CcSEcCtD
Acebutolol—Dermatitis—Capecitabine—breast cancer	4.19e-05	0.000178	CcSEcCtD
Acebutolol—Headache—Capecitabine—breast cancer	4.16e-05	0.000177	CcSEcCtD
Acebutolol—Skin disorder—Doxorubicin—breast cancer	4.16e-05	0.000177	CcSEcCtD
Acebutolol—Paraesthesia—Epirubicin—breast cancer	4.16e-05	0.000176	CcSEcCtD
Acebutolol—Hyperhidrosis—Doxorubicin—breast cancer	4.14e-05	0.000176	CcSEcCtD
Acebutolol—Dyspnoea—Epirubicin—breast cancer	4.13e-05	0.000175	CcSEcCtD
Acebutolol—Somnolence—Epirubicin—breast cancer	4.12e-05	0.000175	CcSEcCtD
Acebutolol—Anorexia—Doxorubicin—breast cancer	4.08e-05	0.000173	CcSEcCtD
Acebutolol—Nausea—Docetaxel—breast cancer	4.08e-05	0.000173	CcSEcCtD
Acebutolol—Feeling abnormal—Methotrexate—breast cancer	4.08e-05	0.000173	CcSEcCtD
Acebutolol—Dyspepsia—Epirubicin—breast cancer	4.08e-05	0.000173	CcSEcCtD
Acebutolol—Gastrointestinal pain—Methotrexate—breast cancer	4.05e-05	0.000172	CcSEcCtD
Acebutolol—Decreased appetite—Epirubicin—breast cancer	4.02e-05	0.000171	CcSEcCtD
Acebutolol—Hypotension—Doxorubicin—breast cancer	4e-05	0.00017	CcSEcCtD
Acebutolol—Gastrointestinal disorder—Epirubicin—breast cancer	4e-05	0.00017	CcSEcCtD
Acebutolol—Fatigue—Epirubicin—breast cancer	3.99e-05	0.000169	CcSEcCtD
Acebutolol—Pain—Epirubicin—breast cancer	3.96e-05	0.000168	CcSEcCtD
Acebutolol—Constipation—Epirubicin—breast cancer	3.96e-05	0.000168	CcSEcCtD
Acebutolol—Nausea—Capecitabine—breast cancer	3.95e-05	0.000168	CcSEcCtD
Acebutolol—Urticaria—Methotrexate—breast cancer	3.93e-05	0.000167	CcSEcCtD
Acebutolol—Abdominal pain—Methotrexate—breast cancer	3.91e-05	0.000166	CcSEcCtD
Acebutolol—Body temperature increased—Methotrexate—breast cancer	3.91e-05	0.000166	CcSEcCtD
Acebutolol—Musculoskeletal discomfort—Doxorubicin—breast cancer	3.9e-05	0.000166	CcSEcCtD
Acebutolol—Insomnia—Doxorubicin—breast cancer	3.87e-05	0.000164	CcSEcCtD
Acebutolol—Paraesthesia—Doxorubicin—breast cancer	3.85e-05	0.000163	CcSEcCtD
Acebutolol—Dyspnoea—Doxorubicin—breast cancer	3.82e-05	0.000162	CcSEcCtD
Acebutolol—Feeling abnormal—Epirubicin—breast cancer	3.82e-05	0.000162	CcSEcCtD
Acebutolol—Somnolence—Doxorubicin—breast cancer	3.81e-05	0.000162	CcSEcCtD
Acebutolol—Gastrointestinal pain—Epirubicin—breast cancer	3.79e-05	0.000161	CcSEcCtD
Acebutolol—Dyspepsia—Doxorubicin—breast cancer	3.77e-05	0.00016	CcSEcCtD
Acebutolol—Decreased appetite—Doxorubicin—breast cancer	3.72e-05	0.000158	CcSEcCtD
Acebutolol—Gastrointestinal disorder—Doxorubicin—breast cancer	3.7e-05	0.000157	CcSEcCtD
Acebutolol—Fatigue—Doxorubicin—breast cancer	3.69e-05	0.000157	CcSEcCtD
Acebutolol—Urticaria—Epirubicin—breast cancer	3.68e-05	0.000156	CcSEcCtD
Acebutolol—Pain—Doxorubicin—breast cancer	3.66e-05	0.000156	CcSEcCtD
Acebutolol—Constipation—Doxorubicin—breast cancer	3.66e-05	0.000156	CcSEcCtD
Acebutolol—Abdominal pain—Epirubicin—breast cancer	3.66e-05	0.000155	CcSEcCtD
Acebutolol—Body temperature increased—Epirubicin—breast cancer	3.66e-05	0.000155	CcSEcCtD
Acebutolol—Asthenia—Methotrexate—breast cancer	3.55e-05	0.000151	CcSEcCtD
Acebutolol—Feeling abnormal—Doxorubicin—breast cancer	3.53e-05	0.00015	CcSEcCtD
Acebutolol—Gastrointestinal pain—Doxorubicin—breast cancer	3.5e-05	0.000149	CcSEcCtD
Acebutolol—Pruritus—Methotrexate—breast cancer	3.5e-05	0.000149	CcSEcCtD
Acebutolol—Urticaria—Doxorubicin—breast cancer	3.4e-05	0.000144	CcSEcCtD
Acebutolol—Abdominal pain—Doxorubicin—breast cancer	3.39e-05	0.000144	CcSEcCtD
Acebutolol—Body temperature increased—Doxorubicin—breast cancer	3.39e-05	0.000144	CcSEcCtD
Acebutolol—Diarrhoea—Methotrexate—breast cancer	3.38e-05	0.000144	CcSEcCtD
Acebutolol—Asthenia—Epirubicin—breast cancer	3.32e-05	0.000141	CcSEcCtD
Acebutolol—Pruritus—Epirubicin—breast cancer	3.28e-05	0.000139	CcSEcCtD
Acebutolol—Dizziness—Methotrexate—breast cancer	3.27e-05	0.000139	CcSEcCtD
Acebutolol—Diarrhoea—Epirubicin—breast cancer	3.17e-05	0.000134	CcSEcCtD
Acebutolol—Vomiting—Methotrexate—breast cancer	3.15e-05	0.000134	CcSEcCtD
Acebutolol—Rash—Methotrexate—breast cancer	3.12e-05	0.000132	CcSEcCtD
Acebutolol—Dermatitis—Methotrexate—breast cancer	3.12e-05	0.000132	CcSEcCtD
Acebutolol—Headache—Methotrexate—breast cancer	3.1e-05	0.000132	CcSEcCtD
Acebutolol—Asthenia—Doxorubicin—breast cancer	3.07e-05	0.00013	CcSEcCtD
Acebutolol—Dizziness—Epirubicin—breast cancer	3.06e-05	0.00013	CcSEcCtD
Acebutolol—Pruritus—Doxorubicin—breast cancer	3.03e-05	0.000129	CcSEcCtD
Acebutolol—Vomiting—Epirubicin—breast cancer	2.94e-05	0.000125	CcSEcCtD
Acebutolol—Nausea—Methotrexate—breast cancer	2.94e-05	0.000125	CcSEcCtD
Acebutolol—Diarrhoea—Doxorubicin—breast cancer	2.93e-05	0.000124	CcSEcCtD
Acebutolol—Rash—Epirubicin—breast cancer	2.92e-05	0.000124	CcSEcCtD
Acebutolol—Dermatitis—Epirubicin—breast cancer	2.92e-05	0.000124	CcSEcCtD
Acebutolol—Headache—Epirubicin—breast cancer	2.9e-05	0.000123	CcSEcCtD
Acebutolol—Dizziness—Doxorubicin—breast cancer	2.83e-05	0.00012	CcSEcCtD
Acebutolol—Nausea—Epirubicin—breast cancer	2.75e-05	0.000117	CcSEcCtD
Acebutolol—Vomiting—Doxorubicin—breast cancer	2.72e-05	0.000116	CcSEcCtD
Acebutolol—Rash—Doxorubicin—breast cancer	2.7e-05	0.000115	CcSEcCtD
Acebutolol—Dermatitis—Doxorubicin—breast cancer	2.7e-05	0.000115	CcSEcCtD
Acebutolol—Headache—Doxorubicin—breast cancer	2.68e-05	0.000114	CcSEcCtD
Acebutolol—Nausea—Doxorubicin—breast cancer	2.54e-05	0.000108	CcSEcCtD
Acebutolol—SLC22A1—Metabolism—ERCC2—breast cancer	8.88e-06	0.000142	CbGpPWpGaD
Acebutolol—ADRB2—GPCR downstream signaling—CXCL8—breast cancer	8.88e-06	0.000142	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—NCOA3—breast cancer	8.85e-06	0.000141	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—CSF2—breast cancer	8.81e-06	0.000141	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—FGF1—breast cancer	8.81e-06	0.000141	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—SLC2A2—breast cancer	8.79e-06	0.00014	CbGpPWpGaD
Acebutolol—ADRB1—Signaling by GPCR—RAF1—breast cancer	8.79e-06	0.00014	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—HES1—breast cancer	8.76e-06	0.00014	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—NRG1—breast cancer	8.74e-06	0.000139	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—PLA2G4A—breast cancer	8.71e-06	0.000139	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—NCOR1—breast cancer	8.71e-06	0.000139	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—ACHE—breast cancer	8.69e-06	0.000139	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—GSTT1—breast cancer	8.69e-06	0.000139	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—H2AFX—breast cancer	8.68e-06	0.000138	CbGpPWpGaD
Acebutolol—ADRB1—GPCR downstream signaling—IL2—breast cancer	8.68e-06	0.000138	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—E2F1—breast cancer	8.62e-06	0.000138	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—FGF1—breast cancer	8.62e-06	0.000137	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—CSF2—breast cancer	8.62e-06	0.000137	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—CPT1A—breast cancer	8.61e-06	0.000137	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—MTR—breast cancer	8.61e-06	0.000137	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—ABCG2—breast cancer	8.61e-06	0.000137	CbGpPWpGaD
Acebutolol—ADRB2—Signaling by GPCR—RAF1—breast cancer	8.6e-06	0.000137	CbGpPWpGaD
Acebutolol—ADRB1—Signaling by GPCR—PIK3CB—breast cancer	8.58e-06	0.000137	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—NRG1—breast cancer	8.55e-06	0.000136	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—H2AFX—breast cancer	8.49e-06	0.000135	CbGpPWpGaD
Acebutolol—ADRB2—GPCR downstream signaling—IL2—breast cancer	8.49e-06	0.000135	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—HPGDS—breast cancer	8.45e-06	0.000135	CbGpPWpGaD
Acebutolol—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—breast cancer	8.44e-06	0.000135	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—E2F1—breast cancer	8.43e-06	0.000135	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—HBA1—breast cancer	8.39e-06	0.000134	CbGpPWpGaD
Acebutolol—ADRB2—Signaling by GPCR—PIK3CB—breast cancer	8.39e-06	0.000134	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—MTHFR—breast cancer	8.35e-06	0.000133	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—SPP1—breast cancer	8.28e-06	0.000132	CbGpPWpGaD
Acebutolol—ADRB1—Signaling by GPCR—CXCL8—breast cancer	8.24e-06	0.000132	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—CYP17A1—breast cancer	8.23e-06	0.000131	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—ACHE—breast cancer	8.19e-06	0.000131	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—GSTT1—breast cancer	8.19e-06	0.000131	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—ERBB3—breast cancer	8.19e-06	0.000131	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—FGFR2—breast cancer	8.18e-06	0.00013	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—PTGS1—breast cancer	8.15e-06	0.00013	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—ENO1—breast cancer	8.15e-06	0.00013	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—SPP1—breast cancer	8.1e-06	0.000129	CbGpPWpGaD
Acebutolol—ADRB2—Signaling by GPCR—CXCL8—breast cancer	8.06e-06	0.000129	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—ERBB3—breast cancer	8.01e-06	0.000128	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—FGFR2—breast cancer	8e-06	0.000128	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—CYP2D6—breast cancer	7.99e-06	0.000127	CbGpPWpGaD
Acebutolol—ADRB1—Signaling by GPCR—IL2—breast cancer	7.88e-06	0.000126	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—TERT—breast cancer	7.85e-06	0.000125	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—NCOA2—breast cancer	7.84e-06	0.000125	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—CYP17A1—breast cancer	7.75e-06	0.000124	CbGpPWpGaD
Acebutolol—ADRB2—Signaling by GPCR—IL2—breast cancer	7.71e-06	0.000123	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—CAV1—breast cancer	7.7e-06	0.000123	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—TERT—breast cancer	7.68e-06	0.000123	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—ENO1—breast cancer	7.68e-06	0.000122	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—PTGS1—breast cancer	7.68e-06	0.000122	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—FGFR1—breast cancer	7.62e-06	0.000122	CbGpPWpGaD
Acebutolol—ABCB1—Transmembrane transport of small molecules—ALB—breast cancer	7.62e-06	0.000122	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—FASN—breast cancer	7.61e-06	0.000121	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—BCHE—breast cancer	7.57e-06	0.000121	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—HIF1A—breast cancer	7.51e-06	0.00012	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—SLC5A5—breast cancer	7.48e-06	0.000119	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—FGFR1—breast cancer	7.46e-06	0.000119	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—NCOA2—breast cancer	7.39e-06	0.000118	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—HIF1A—breast cancer	7.34e-06	0.000117	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—LEP—breast cancer	7.33e-06	0.000117	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—CAV1—breast cancer	7.26e-06	0.000116	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—NQO1—breast cancer	7.23e-06	0.000115	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—SLC2A1—breast cancer	7.23e-06	0.000115	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—KDR—breast cancer	7.18e-06	0.000115	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—LEP—breast cancer	7.17e-06	0.000114	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—FASN—breast cancer	7.17e-06	0.000114	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—BCHE—breast cancer	7.14e-06	0.000114	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—CAV1—breast cancer	7.1e-06	0.000113	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—SLC5A5—breast cancer	7.05e-06	0.000112	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—CYP3A4—breast cancer	7.05e-06	0.000112	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—KDR—breast cancer	7.02e-06	0.000112	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—PIK3CG—breast cancer	7.02e-06	0.000112	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—ESR1—breast cancer	7e-06	0.000112	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—CYP1B1—breast cancer	6.93e-06	0.000111	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—FN1—breast cancer	6.91e-06	0.00011	CbGpPWpGaD
Acebutolol—ABCB1—Transmembrane transport of small molecules—RAF1—breast cancer	6.89e-06	0.00011	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—ESR1—breast cancer	6.84e-06	0.000109	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—NFKBIA—breast cancer	6.83e-06	0.000109	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—NQO1—breast cancer	6.81e-06	0.000109	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—SLC2A1—breast cancer	6.81e-06	0.000109	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—HSP90AA1—breast cancer	6.79e-06	0.000108	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—NOTCH1—breast cancer	6.76e-06	0.000108	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—FN1—breast cancer	6.76e-06	0.000108	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—NFKBIA—breast cancer	6.68e-06	0.000107	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—CYP3A4—breast cancer	6.64e-06	0.000106	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—NOTCH1—breast cancer	6.62e-06	0.000106	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—KIT—breast cancer	6.61e-06	0.000106	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—PIK3CG—breast cancer	6.61e-06	0.000106	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—APC—breast cancer	6.61e-06	0.000106	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—NCOA1—breast cancer	6.61e-06	0.000105	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—EGF—breast cancer	6.54e-06	0.000104	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—CYP1B1—breast cancer	6.53e-06	0.000104	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—STK11—breast cancer	6.51e-06	0.000104	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—CYP19A1—breast cancer	6.51e-06	0.000104	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—APC—breast cancer	6.47e-06	0.000103	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—KIT—breast cancer	6.47e-06	0.000103	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—PIK3CG—breast cancer	6.47e-06	0.000103	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—HSP90AA1—breast cancer	6.4e-06	0.000102	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—EGF—breast cancer	6.4e-06	0.000102	CbGpPWpGaD
Acebutolol—ADRB1—Signaling by GPCR—MAPK3—breast cancer	6.33e-06	0.000101	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—NCOA1—breast cancer	6.23e-06	9.93e-05	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—BRAF—breast cancer	6.22e-06	9.92e-05	CbGpPWpGaD
Acebutolol—ADRB2—Signaling by GPCR—MAPK3—breast cancer	6.2e-06	9.89e-05	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—PIK3CD—breast cancer	6.17e-06	9.84e-05	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—CYP19A1—breast cancer	6.14e-06	9.79e-05	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—STK11—breast cancer	6.14e-06	9.79e-05	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—ALB—breast cancer	6.09e-06	9.71e-05	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—BRAF—breast cancer	6.08e-06	9.7e-05	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—IGF1—breast cancer	6.06e-06	9.66e-05	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—COMT—breast cancer	6.05e-06	9.66e-05	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—AKT2—breast cancer	6.05e-06	9.65e-05	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—GSTP1—breast cancer	6.03e-06	9.61e-05	CbGpPWpGaD
Acebutolol—ADRB1—Signaling by GPCR—EGFR—breast cancer	6.03e-06	9.61e-05	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—HMOX1—breast cancer	5.94e-06	9.48e-05	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—ITPR1—breast cancer	5.93e-06	9.46e-05	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—IGF1—breast cancer	5.92e-06	9.45e-05	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—AKT2—breast cancer	5.92e-06	9.44e-05	CbGpPWpGaD
Acebutolol—ADRB2—Signaling by GPCR—EGFR—breast cancer	5.89e-06	9.4e-05	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—NOS3—breast cancer	5.82e-06	9.29e-05	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—PIK3CD—breast cancer	5.81e-06	9.28e-05	CbGpPWpGaD
Acebutolol—ADRB1—GPCR downstream signaling—PIK3CA—breast cancer	5.76e-06	9.19e-05	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—SERPINE1—breast cancer	5.75e-06	9.17e-05	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—COMT—breast cancer	5.71e-06	9.1e-05	CbGpPWpGaD
Acebutolol—ADRB1—Signaling by GPCR—KRAS—breast cancer	5.69e-06	9.08e-05	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—PIK3CD—breast cancer	5.69e-06	9.07e-05	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—GSTP1—breast cancer	5.68e-06	9.06e-05	CbGpPWpGaD
Acebutolol—ADRB2—GPCR downstream signaling—PIK3CA—breast cancer	5.63e-06	8.99e-05	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—SERPINE1—breast cancer	5.63e-06	8.97e-05	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—TYMS—breast cancer	5.6e-06	8.94e-05	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—HMOX1—breast cancer	5.6e-06	8.93e-05	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—ITPR1—breast cancer	5.59e-06	8.91e-05	CbGpPWpGaD
Acebutolol—ADRB2—Signaling by GPCR—KRAS—breast cancer	5.57e-06	8.88e-05	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—NCOR1—breast cancer	5.54e-06	8.83e-05	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—GSTM1—breast cancer	5.54e-06	8.83e-05	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—PLA2G4A—breast cancer	5.54e-06	8.83e-05	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—NOS3—breast cancer	5.49e-06	8.76e-05	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—PIK3CB—breast cancer	5.38e-06	8.58e-05	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—ABCB1—breast cancer	5.38e-06	8.58e-05	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—NOS3—breast cancer	5.37e-06	8.57e-05	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—PTGS2—breast cancer	5.33e-06	8.5e-05	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—GPX1—breast cancer	5.3e-06	8.46e-05	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—TYMS—breast cancer	5.28e-06	8.42e-05	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—CYP1A1—breast cancer	5.25e-06	8.38e-05	CbGpPWpGaD
Acebutolol—ADRB1—Signaling by GPCR—PIK3CA—breast cancer	5.23e-06	8.34e-05	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—PLA2G4A—breast cancer	5.22e-06	8.33e-05	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—GSTM1—breast cancer	5.22e-06	8.33e-05	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—NCOR1—breast cancer	5.22e-06	8.33e-05	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—MDM2—breast cancer	5.21e-06	8.31e-05	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—ERCC2—breast cancer	5.21e-06	8.31e-05	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—RAF1—breast cancer	5.19e-06	8.28e-05	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—RELA—breast cancer	5.17e-06	8.24e-05	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—ERBB2—breast cancer	5.14e-06	8.19e-05	CbGpPWpGaD
Acebutolol—ADRB2—Signaling by GPCR—PIK3CA—breast cancer	5.12e-06	8.16e-05	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—MDM2—breast cancer	5.1e-06	8.13e-05	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—RAF1—breast cancer	5.08e-06	8.1e-05	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—MTOR—breast cancer	5.07e-06	8.09e-05	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—PIK3CB—breast cancer	5.07e-06	8.09e-05	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—RELA—breast cancer	5.06e-06	8.07e-05	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—ERBB2—breast cancer	5.02e-06	8.01e-05	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—GPX1—breast cancer	5e-06	7.97e-05	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—MTOR—breast cancer	4.96e-06	7.91e-05	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—PIK3CB—breast cancer	4.96e-06	7.91e-05	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—CYP1A1—breast cancer	4.95e-06	7.89e-05	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—ERCC2—breast cancer	4.91e-06	7.83e-05	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—MTHFR—breast cancer	4.89e-06	7.81e-05	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—CXCL8—breast cancer	4.87e-06	7.77e-05	CbGpPWpGaD
Acebutolol—ADRB1—Signaling by GPCR—HRAS—breast cancer	4.84e-06	7.72e-05	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—CXCL8—breast cancer	4.76e-06	7.6e-05	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—CDKN1B—breast cancer	4.76e-06	7.59e-05	CbGpPWpGaD
Acebutolol—ADRB2—Signaling by GPCR—HRAS—breast cancer	4.73e-06	7.55e-05	CbGpPWpGaD
Acebutolol—ADRB1—GPCR downstream signaling—AKT1—breast cancer	4.7e-06	7.51e-05	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—CASP3—breast cancer	4.66e-06	7.44e-05	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—IL2—breast cancer	4.65e-06	7.43e-05	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—CDKN1B—breast cancer	4.65e-06	7.42e-05	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—PTEN—breast cancer	4.65e-06	7.41e-05	CbGpPWpGaD
Acebutolol—ADRB1—Signaling by GPCR—IL6—breast cancer	4.63e-06	7.39e-05	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—MTHFR—breast cancer	4.61e-06	7.36e-05	CbGpPWpGaD
Acebutolol—ADRB2—GPCR downstream signaling—AKT1—breast cancer	4.6e-06	7.34e-05	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—CASP3—breast cancer	4.56e-06	7.27e-05	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—IL2—breast cancer	4.55e-06	7.26e-05	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—CCND1—breast cancer	4.54e-06	7.24e-05	CbGpPWpGaD
Acebutolol—ADRB2—Signaling by GPCR—IL6—breast cancer	4.53e-06	7.23e-05	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—JUN—breast cancer	4.53e-06	7.22e-05	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—CAV1—breast cancer	4.51e-06	7.2e-05	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—CTNNB1—breast cancer	4.49e-06	7.17e-05	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—CCND1—breast cancer	4.44e-06	7.08e-05	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—JUN—breast cancer	4.43e-06	7.07e-05	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—MMP9—breast cancer	4.4e-06	7.03e-05	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—CTNNB1—breast cancer	4.4e-06	7.01e-05	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—CDKN1A—breast cancer	4.39e-06	7e-05	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—PTEN—breast cancer	4.38e-06	6.99e-05	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—MMP9—breast cancer	4.31e-06	6.87e-05	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—CDKN1A—breast cancer	4.29e-06	6.85e-05	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—MAPK8—breast cancer	4.28e-06	6.83e-05	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—PTEN—breast cancer	4.28e-06	6.83e-05	CbGpPWpGaD
Acebutolol—ADRB1—Signaling by GPCR—AKT1—breast cancer	4.27e-06	6.82e-05	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—CAV1—breast cancer	4.25e-06	6.79e-05	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—MAPK8—breast cancer	4.19e-06	6.69e-05	CbGpPWpGaD
Acebutolol—ADRB2—Signaling by GPCR—AKT1—breast cancer	4.18e-06	6.67e-05	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—PIK3CG—breast cancer	4.11e-06	6.56e-05	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—SRC—breast cancer	4.06e-06	6.48e-05	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—SRC—breast cancer	3.97e-06	6.34e-05	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—VEGFA—breast cancer	3.96e-06	6.31e-05	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—STAT3—breast cancer	3.92e-06	6.25e-05	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—PIK3CG—breast cancer	3.87e-06	6.18e-05	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—VEGFA—breast cancer	3.87e-06	6.17e-05	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—STAT3—breast cancer	3.83e-06	6.11e-05	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—MAPK3—breast cancer	3.74e-06	5.97e-05	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—MAPK3—breast cancer	3.66e-06	5.84e-05	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—MYC—breast cancer	3.64e-06	5.81e-05	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—TGFB1—breast cancer	3.63e-06	5.79e-05	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—PIK3CD—breast cancer	3.61e-06	5.77e-05	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—ALB—breast cancer	3.57e-06	5.69e-05	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—MYC—breast cancer	3.56e-06	5.68e-05	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—EGFR—breast cancer	3.56e-06	5.68e-05	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—TGFB1—breast cancer	3.55e-06	5.67e-05	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—EGFR—breast cancer	3.48e-06	5.56e-05	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—NOS3—breast cancer	3.41e-06	5.45e-05	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—PIK3CD—breast cancer	3.41e-06	5.43e-05	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—KRAS—breast cancer	3.36e-06	5.36e-05	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—ALB—breast cancer	3.36e-06	5.36e-05	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—KRAS—breast cancer	3.29e-06	5.25e-05	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—PIK3CA—breast cancer	3.28e-06	5.23e-05	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—NOS3—breast cancer	3.22e-06	5.13e-05	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—PIK3CB—breast cancer	3.15e-06	5.03e-05	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—PTGS2—breast cancer	3.12e-06	4.98e-05	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—PIK3CA—breast cancer	3.09e-06	4.93e-05	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—PIK3CA—breast cancer	3.02e-06	4.82e-05	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—TP53—breast cancer	2.99e-06	4.77e-05	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—PIK3CB—breast cancer	2.97e-06	4.74e-05	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—PTGS2—breast cancer	2.94e-06	4.69e-05	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—TP53—breast cancer	2.92e-06	4.66e-05	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—HRAS—breast cancer	2.86e-06	4.56e-05	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—HRAS—breast cancer	2.8e-06	4.46e-05	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—IL6—breast cancer	2.74e-06	4.36e-05	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—PTEN—breast cancer	2.72e-06	4.34e-05	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—AKT1—breast cancer	2.68e-06	4.27e-05	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—IL6—breast cancer	2.68e-06	4.27e-05	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—PTEN—breast cancer	2.57e-06	4.09e-05	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—AKT1—breast cancer	2.52e-06	4.03e-05	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—AKT1—breast cancer	2.47e-06	3.94e-05	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—PIK3CA—breast cancer	1.92e-06	3.06e-05	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—PIK3CA—breast cancer	1.81e-06	2.89e-05	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—AKT1—breast cancer	1.57e-06	2.5e-05	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—AKT1—breast cancer	1.48e-06	2.36e-05	CbGpPWpGaD
